Stocktoria
Atara Biotherapeutics, Inc. ATRA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-10-16
Chart by TradingView
5/9
Piotroski F — financial health
-315.39
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $120.8M | $128.9M | $8.6M | $63.6M | — |
| Operating income | $35.9M | -$83.4M | -$276.0M | -$280.5M | -$340.5M |
| Net income | $32.7M | -$85.4M | -$276.1M | -$228.3M | -$340.1M |
| Operating cash flow | -$50.9M | -$68.7M | -$193.0M | -$270.4M | -$220.5M |
| Free cash flow | -$50.9M | -$69.0M | -$194.2M | -$274.6M | -$231.1M |
| Total assets | $20.2M | $109.1M | $165.5M | $376.4M | $468.1M |
| Total liabilities | $58.7M | $206.4M | $264.7M | $249.8M | $188.5M |
| Shareholders' equity | -$38.5M | -$97.3M | $99.2M | $126.6M | $279.6M |
| Ratios | |||||
| Operating margin | 29.7% | -64.7% | -3219.5% | -441.2% | — |
| Net margin | 27.1% | -66.2% | -3220.9% | -359.1% | — |
| FCF margin | -42.2% | -53.5% | -2265.3% | -432.0% | — |
| Return on assets | 161.5% | -78.3% | -166.8% | -60.7% | -72.7% |
| Return on equity | -84.9% | 87.8% | -278.3% | -180.3% | -121.6% |
| Current ratio | 0.82 | 0.48 | 0.72 | 3.74 | 3.64 |
| Revenue growth | -6.3% | 1404.0% | -86.5% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 194,264 | $918,869 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -315.39 (distress)
- Working capital / assets -0.134
- Retained earnings / assets -99.919
- EBIT / assets 1.772
- Equity / liabilities -0.655
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001604464 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.